ReviewAJOG global reports2025
Depression and associated factors among human immunodeficiency virus-positive pregnant women in sub-Saharan Africa: systematic review and meta-analysis.
Review in AJOG global reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Qualitative findings on the benefits of depression treatment for pregnant women living with HIV in Uganda.Global mental health (Cambridge, England) · 2026Article
- Disclosure and peer support in prevention of mother-to-child transmission of human immunodeficiency virus: Evidence from Rwanda.World journal of virology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite its severe impact on both maternal and fetal health, antenatal depression has not received as much attention in the healthcare community as postnatal depression. Comprehensive evidence is very important to suggest informed decisions and strategies to the Ministry of Health. Therefore, this study aims to estimate the pooled prevalence of depression and to identify associated factors among pregnant women living with human immunodeficiency virus (HIV)/AIDS in sub-Saharan Africa. Method: Between May 15, 2024, and June 21, 2024, a systematic and thorough literature search was conducted using reputable electronic databases (PubMed, Cochrane Library) and web sources (Science Direct, African Journals Online, Google Scholar). The quality of the included studies was assessed using the Joanna Briggs Institute critical appraisal checklist for analytical cross-sectional studies, which includes 9 criteria. Heterogeneity among the studies was examined using Cochrane's Q and Result: The initial database search yielded 39,000 articles. The pooled prevalence of depression among pregnant women living with HIV/AIDS in sub-Saharan Africa was estimated to be 39.86% (95% confidence interval [CI]: 34.89-44.83, Conclusion: Over one-third of pregnant women with HIV/AIDS experience depression, linked to factors like intimate partner violence, food insecurity, and poor adherence to antiretroviral therapy. Prioritize tailored mental health services and peer support groups. Increase education on intimate partner violence and implement nutritional support programs. Promote community initiatives and simplify ART regimens for improved health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.